IL326645A - תרכובות פרמצבטיות המכילות מעכב פי.קי.סי. - Google Patents
תרכובות פרמצבטיות המכילות מעכב פי.קי.סי.Info
- Publication number
- IL326645A IL326645A IL326645A IL32664526A IL326645A IL 326645 A IL326645 A IL 326645A IL 326645 A IL326645 A IL 326645A IL 32664526 A IL32664526 A IL 32664526A IL 326645 A IL326645 A IL 326645A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- pkc inhibitor
- pkc
- inhibitor
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363520857P | 2023-08-21 | 2023-08-21 | |
| PCT/US2024/043216 WO2025042981A2 (en) | 2023-08-21 | 2024-08-21 | Pharmaceutical compositions comprising a pkc inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326645A true IL326645A (he) | 2026-04-01 |
Family
ID=94732761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326645A IL326645A (he) | 2023-08-21 | 2024-08-21 | תרכובות פרמצבטיות המכילות מעכב פי.קי.סי. |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN121889149A (he) |
| AU (1) | AU2024327543A1 (he) |
| IL (1) | IL326645A (he) |
| WO (1) | WO2025042981A2 (he) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3589B1 (ar) * | 2014-08-06 | 2020-07-05 | Novartis Ag | مثبطات كيناز البروتين c وطرق استخداماتها |
| CA3167275A1 (en) * | 2020-01-29 | 2021-08-05 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
| US12383555B2 (en) * | 2020-05-20 | 2025-08-12 | Foghorn Therapeutics Inc. | Methods of treating cancers |
-
2024
- 2024-08-21 AU AU2024327543A patent/AU2024327543A1/en active Pending
- 2024-08-21 IL IL326645A patent/IL326645A/he unknown
- 2024-08-21 WO PCT/US2024/043216 patent/WO2025042981A2/en active Pending
- 2024-08-21 CN CN202480057502.XA patent/CN121889149A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025042981A2 (en) | 2025-02-27 |
| AU2024327543A1 (en) | 2026-03-12 |
| WO2025042981A3 (en) | 2025-04-24 |
| CN121889149A (zh) | 2026-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL192357A0 (en) | Pharmaceutical compositions containing a farnesyl transferase inhibitor | |
| IL321625A (he) | מעכבי malt1 | |
| IL304525A (he) | תכשיר רוקחות המכיל תולדה של דיפנילפיראזין | |
| GB202008201D0 (en) | Inhibitor compounds | |
| IL314049A (he) | מעכבי parp7 | |
| GB202004960D0 (en) | Inhibitor compounds | |
| GB202110373D0 (en) | Inhibitor compounds | |
| GB202300881D0 (en) | Inhibitor compounds | |
| IL326645A (he) | תרכובות פרמצבטיות המכילות מעכב פי.קי.סי. | |
| CA3301500A1 (en) | Pharmaceutical compositions comprising a pkc inhibitor | |
| GB202307924D0 (en) | Inhibitor compounds | |
| IL313622A (he) | תרכובות המורכבות מקולטן כימוקיני מעכב מסלול | |
| AU2024217004A1 (en) | Solid oral pharmaceutical compositions including alkyl 3,4,5‑trihydroxybenzoate as a nitrosamine inhibitor | |
| IL314046A (he) | תכשירים תרופתיים של ribociclib | |
| CA3298102A1 (en) | Pharmaceutical compositions comprising a menin inhibitor | |
| PL4279075T3 (pl) | Kompozycja farmaceutyczna zawierająca elagoliks | |
| HK40101114A (en) | Pharmaceutical compositions of a kinase inhibitor | |
| HK40079685A (en) | Pharmaceutical compositions of a kinase inhibitor | |
| GB202306601D0 (en) | Inhibitor compounds | |
| IL325676A (he) | מעכבים של kat6 | |
| GB202215245D0 (en) | Inhibitor compounds | |
| GB202207972D0 (en) | Inhibitor compounds | |
| HK40111764A (en) | Compositions comprising a chemokine receptor pathway inhibitor | |
| GB202418176D0 (en) | Inhibitor compounds | |
| GB202417501D0 (en) | Inhibitor compounds |